<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27185954</article-id>
<article-id pub-id-type="pmc">4896683</article-id>
<article-id pub-id-type="publisher-id">201600084</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1600084113</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Genetics</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy</article-title>
<alt-title alt-title-type="short">SP110 variants modify risk in canine model of ALS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ivansson</surname>
<given-names>Emma L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-1458-0865</contrib-id>
<name>
<surname>Megquier</surname>
<given-names>Kate</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kozyrev</surname>
<given-names>Sergey V.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murén</surname>
<given-names>Eva</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Körberg</surname>
<given-names>Izabella Baranowska</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="author-notes" rid="fn3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Swofford</surname>
<given-names>Ross</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koltookian</surname>
<given-names>Michele</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tonomura</surname>
<given-names>Noriko</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeng</surname>
<given-names>Rong</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kolicheski</surname>
<given-names>Ana L.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hansen</surname>
<given-names>Liz</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Katz</surname>
<given-names>Martin L.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johnson</surname>
<given-names>Gayle C.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johnson</surname>
<given-names>Gary S.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coates</surname>
<given-names>Joan R.</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lindblad-Toh</surname>
<given-names>Kerstin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, <institution>Uppsala University</institution>, 751 23 Uppsala, <country>Sweden</country>;</aff>
<aff id="aff2"><sup>b</sup><institution>Broad Institute of Harvard and Massachusetts Institute of Technology</institution>, Cambridge, <addr-line>MA</addr-line> 02142;</aff>
<aff id="aff3"><sup>c</sup>Department of Animal Breeding and Genetics, <institution>Swedish University of Agricultural Sciences</institution>, 750 07 Uppsala, <country>Sweden</country>;</aff>
<aff id="aff4"><sup>d</sup>Department of Clinical Sciences, <institution>Cummings School of Veterinary Medicine at Tufts University</institution>, North Grafton, <addr-line>MA</addr-line> 01536;</aff>
<aff id="aff5"><sup>e</sup>Department of Veterinary Pathobiology, College of Veterinary Medicine, <institution>University of Missouri</institution>, Columbia, <addr-line>MO</addr-line> 65211;</aff>
<aff id="aff6"><sup>f</sup>Mason Eye Institute, School of Medicine, <institution>University of Missouri</institution>, Columbia, <addr-line>MO</addr-line> 65201;</aff>
<aff id="aff7"><sup>g</sup>Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, <institution>University of Missouri</institution>, Columbia, <addr-line>MO</addr-line> 65211</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence may be addressed. Email: <email>emma.ivansson@ki.se</email> or <email>kersli@broadinstitute.org</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Stephen T. Warren, Emory University School of Medicine, Atlanta, GA, and approved April 15, 2016 (received for review January 7, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: E.L.I. and K.L.-T. designed research; E.L.I., K.M., S.V.K., E.M., I.B.K., R.S., M.K., N.T., R.Z., A.L.K., L.H., M.L.K., G.C.J., G.S.J., J.R.C., and K.L.-T. performed research; E.L.I., K.M., and S.V.K. analyzed data; and E.L.I. and K.M. wrote the paper.</p>
</fn>
<fn fn-type="present-address" id="fn2">
<p><sup>2</sup>Present address: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77, Stockholm, Sweden.</p>
</fn>
<fn fn-type="present-address" id="fn3">
<p><sup>3</sup>Present address: Department of Women’s and Children’s Health, Karolinska Institutet, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.</p>
</fn>
<fn fn-type="conflict">
<p>Conflict of interest statement: A DNA test to identify dogs at risk of developing degenerative myelopathy is the subject of four awarded patents (European Patent 2247752, Australian Patent 2009212473, Japanese Patent 5584916, and Mexico Patent 326951) and one pending patent application (Canada Patent 2,714,393). Three of the coauthors (G.S.J., J.R.C., and K.L.-T.) are co-inventors listed on these patents and patent applications. A patent application was filed as to certain subject matter of this manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>31</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>5</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
<volume>113</volume>
<issue>22</issue>
<fpage>E3091</fpage>
<lpage>E3100</lpage>
<permissions>
<license license-type="open-access">
<license-p>Freely available online through the PNAS open access option.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201600084.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Degenerative myelopathy (DM) is a canine disease very similar to amyotrophic lateral sclerosis (ALS) in humans. We previously showed that DM is a promising model for ALS, because genome-wide association identified a mutation in superoxide dismutase 1 gene (<italic>SOD1</italic>), a known ALS gene. This mutation found in many dog breeds increases the risk of DM, and the pathological findings and clinical progression of the two diseases are similar. In this study, we identify a modifier gene, SP110 nuclear body protein (<italic>SP110</italic>)<italic>,</italic> which strongly affects overall disease risk and age of onset in Pembroke Welsh Corgis at risk for DM. Dissecting the complex genetics of this disease in a model organism may lead to new insights about risk and progression in both canine and human patients.</p>
</abstract>
<abstract>
<p>Canine degenerative myelopathy (DM) is a naturally occurring neurodegenerative disease with similarities to some forms of amyotrophic lateral sclerosis (ALS). Most dogs that develop DM are homozygous for a common superoxide dismutase 1 gene (<italic>SOD1</italic>) mutation. However, not all dogs homozygous for this mutation develop disease. We performed a genome-wide association analysis in the Pembroke Welsh Corgi (PWC) breed comparing DM-affected and -unaffected dogs homozygous for the <italic>SOD1</italic> mutation. The analysis revealed a modifier locus on canine chromosome 25. A haplotype within the SP110 nuclear body protein (<italic>SP110</italic>) was present in 40% of affected compared with 4% of unaffected dogs (<italic>P</italic> = 1.5 × 10<sup>−5</sup>), and was associated with increased probability of developing DM (<italic>P</italic> = 4.8 × 10<sup>−6</sup>) and earlier onset of disease (<italic>P</italic> = 1.7 × 10<sup>−5</sup>). SP110 is a nuclear body protein involved in the regulation of gene transcription. Our findings suggest that variations in SP110-mediated gene transcription may underlie, at least in part, the variability in risk for developing DM among PWCs that are homozygous for the disease-related <italic>SOD1</italic> mutation. Further studies are warranted to clarify the effect of this modifier across dog breeds.</p>
</abstract>
<kwd-group>
<kwd>degenerative myelopathy</kwd>
<kwd>amyotrophic lateral sclerosis</kwd>
<kwd>ALS</kwd>
<kwd>SOD1</kwd>
<kwd>SP110</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">American Kennel Club Canine Health Foundation (American Kennel Club Canine Health Foundation, Inc.)<named-content content-type="funder-id">100001458</named-content></funding-source>
<award-id rid="sp1">01271A</award-id>
<award-id rid="sp1">01212A</award-id>
<award-id rid="sp1">01213A</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">ALS Association</funding-source>
<award-id rid="sp2">48892</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>